{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:07:08Z","timestamp":1761934028235,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Mycology Case Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.mmcr.2019.10.002","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T11:34:28Z","timestamp":1570102468000},"page":"42-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Cutaneous mucormycosis by Rhizopus arrhizus treated with isavuconazole as first line therapy: A case report"],"prefix":"10.1016","volume":"26","author":[{"given":"G.","family":"Zuglian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ripamonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tebaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mmcr.2019.10.002_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.mmcr.2019.10.002_bib2","first-page":"79","article-title":"Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections","volume":"9","author":"Donnelley","year":"2016","journal-title":"Infect. Drug Resist."},{"issue":"7","key":"10.1016\/j.mmcr.2019.10.002_bib3","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"suppl_1","key":"10.1016\/j.mmcr.2019.10.002_bib4","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.mmcr.2019.10.002_bib5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mmcr.2019.10.002_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1469-0691.2009.02979.x","article-title":"Cutaneous zygomycosis","volume":"15","author":"Skiada","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"issue":"4","key":"10.1016\/j.mmcr.2019.10.002_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clindermatol.2011.09.013","article-title":"Cutaneous zygomycosis","volume":"30","author":"Bonifaz","year":"2012","journal-title":"Clin. Dermatol."},{"issue":"7","key":"10.1016\/j.mmcr.2019.10.002_bib8","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.injury.2016.03.011","article-title":"Cutaneous mucormycosis secondary to penetrative trauma","volume":"47","author":"Zahoor","year":"2016","journal-title":"Injury"},{"issue":"1","key":"10.1016\/j.mmcr.2019.10.002_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/clinids\/19.1.67","article-title":"Mucormycosis: emerging prominence of cutaneous infections","volume":"19","author":"Adam","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mmcr.2019.10.002_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijid.2017.07.002","article-title":"Invasive fungal infections secondary to traumatic injury","volume":"62","author":"Kronen","year":"2017","journal-title":"Int. J. Infect. Dis."},{"issue":"24","key":"10.1016\/j.mmcr.2019.10.002_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000221","article-title":"Posttraumatic mucormycosis: a nationwide study in France and review of the literature","volume":"93","author":"Lelievre","year":"2014","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.mmcr.2019.10.002_bib12","article-title":"Cutaneous mucormycosis in solid organ transplant recipients after hurricane harvey: short-and long-term management","volume":"7","author":"Kueht","year":"2019","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"issue":"3","key":"10.1016\/j.mmcr.2019.10.002_bib13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/JCM.03176-13","article-title":"Isavuconazole treatment of a patient with disseminated mucormycosis","volume":"52","author":"Peixoto","year":"2014","journal-title":"J. Clin. Microbiol."},{"issue":"10","key":"10.1016\/j.mmcr.2019.10.002_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01230-18","article-title":"In vitro activity of isavuconazole against opportunistic fungal pathogens from two mycology reference laboratories","volume":"62","author":"Pfaller","year":"2018","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Medical Mycology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211753919300740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211753919300740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:02:18Z","timestamp":1761933738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211753919300740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":14,"alternative-id":["S2211753919300740"],"URL":"https:\/\/doi.org\/10.1016\/j.mmcr.2019.10.002","relation":{},"ISSN":["2211-7539"],"issn-type":[{"type":"print","value":"2211-7539"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous mucormycosis by Rhizopus arrhizus treated with isavuconazole as first line therapy: A case report","name":"articletitle","label":"Article Title"},{"value":"Medical Mycology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mmcr.2019.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.","name":"copyright","label":"Copyright"}]}}